Gliclazide and Enzalutamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gliclazide (gliclazide) and Enzalutamide (enzalutamide). Common drug interactions include chronic obstructive pulmonary disease among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Gliclazide and Enzalutamide. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Enzalutamide?

Enzalutamide has active ingredients of enzalutamide. eHealthMe is studying from 14,018 Enzalutamide users. Check the latest studies of Enzalutamide.

On Jul, 11, 2026

29 people who take Gliclazide and Enzalutamide together, and have interactions are studied.

Gliclazide and Enzalutamide drug interactions.

What are the common drug interactions of Gliclazide and Enzalutamide, by gender? *:

female:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
General physical health deterioration (weak health status)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

male:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Hypertension (high blood pressure)
Pyrexia (fever)
Urine flow decreased
Muscle contractions involuntary (uncontrolled muscle contraction)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Anaemia (lack of blood)
Asthenia (weakness)
Decreased appetite

What are the common drug interactions of Gliclazide and Enzalutamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Hypertension (high blood pressure)
Pyrexia (fever)
Urine flow decreased
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Anaemia (lack of blood)
Asthenia (weakness)
Decreased appetite

What are the existing conditions these people have? *

Prostate Cancer: 11 people, 37.93%
High Blood Pressure: 5 people, 17.24%
Pain: 4 people, 13.79%
High Blood Cholesterol: 3 people, 10.34%
Prostate Cancer Metastatic: 2 people, 6.90%
Constipation: 2 people, 6.90%
Breast Cancer: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and Enzalutamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously